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Abstract 1 
 2 
Live-imaging techniques are at the forefront of biology research to explore behaviour 3 
and function from sub-cellular to whole organism scales. These methods rely on intracellular 4 
fluorescent probes to label specific proteins, which are commonly assumed to only introduce 5 
artefacts at concentrations far-exceeding routine use. Lifeact, a small peptide with affinity for 6 
actin microfilaments has become a gold standard in live cell imaging of the cytoskeleton. 7 
Nevertheless, recent reports have raised concerns on Lifeact-associated artefacts at the 8 
molecular and whole organism level. We show here that Lifeact induces dose-response 9 
artefacts at the cellular level, impacting stress fibre dynamics and actin cytoskeleton 10 
architecture. These effects extend to the microtubule and intermediate filament networks as 11 
well as the nucleus, and ultimately lead to altered subcellular localization of YAP, reduced 12 
cell migration and abnormal mechanical properties. Our results suggest that reduced binding 13 
of cofilin to actin filaments may be the underlying cause of the observed Lifeact-induced 14 
cellular artefacts.    15 
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Introduction 1 
 2 
Live-cell actin visualization is routinely performed and presented in a large percent of 3 
cell biology research, including studies where actin or the cytoskeleton may only be 4 
secondary players on the observations reported. Lifeact, a small peptide with affinity for actin 5 
microfilaments1-3, has become one of the gold standards in live cell imaging of actin 6 
structures in particular, and overall cell morphology in general. A number of reports have 7 
assessed the suitability of Lifeact as a cytoskeletal marker, focusing primarily on qualitative 8 
observations of which structures are preferentially labelled by Lifeact relative to other probes 9 
such as phalloidin, utrophin or actin-GFP4,5. It has been recently reported that Lifeact alters 10 
actin filament arrangement and dynamics in fission yeast cells6. Similarly, strong in vivo 11 
Lifeact expression causes sterility in fruit flies7, associated with severe actin defects and 12 
multiple nuclei in follicle cells. In addition, the detrimental effects of strong Lifeact expression 13 
in cells appear to be linked to the specific promoter and fluorescent protein tag used8,9. The 14 
aforementioned studies have focused on highlighting the abnormal morphologies, dynamics 15 
and overall behaviour of cells associated with strong Lifeact expression. Nevertheless, it 16 
remains to be discerned whether low to mid-level expression of Lifeact results in unaltered 17 
actin dynamics, or conversely if Lifeact induces broad dose-dependent effects on the actin 18 
cytoskeleton. Such an understanding is still missing to better define the experimental 19 
conditions under which Lifeact is to be considered a suitable probe to image actin structures.   20 
 21 
 22 
 23 
Results 24 
 25 
Cell cultures transduced with Lifeact-GFP display altered morphologies  26 
In our experiments, we first performed an overnight transduction of human 27 
Mesenchymal Stem Cells (hMSCs) with increasing concentrations (presented as Multiplicity 28 
of Infection - MOI) of commercial adenoviral vectors delivering rAVCMV-LifeAct-29 
TagGFP2 plasmid. We transduced cells with MOI ranging from low levels (MOI 100) up to 30 
the highest dose recommended by the supplier (MOI 1000). Samples were fixed 1-7 days 31 
post transduction, co-stained with TRITC-phalloidin and DAPI, and subsequently imaged via 32 
standard epifluorescence microscopy at 20x magnification (Supplementary Fig. 1 and 33 
Supplementary Table 1). When pooling together data at the population level, we found a 34 
statistically significant increase in GFP intensity for experiments using higher MOIs 35 
(Supplementary Fig. 2). Likewise, we found that GFP levels significantly changed with 36 
increasing expression time, with the peak of expression occurring 5 days post transduction. 37 
4 
 
Surprisingly, we found comparable trends when we measured simple parameters that 1 
describe cellular morphology and actin assembly, such as cell area and filamentous-actin (F-2 
actin) amount (Supplementary Fig. 3). These analogous temporal and concentration-3 
dependent trends observed at the population level suggested that intracellular Lifeact may 4 
result in altered cellular and cytoskeletal morphology. 5 
 6 
Lifeact-GFP alters actin organization in a dose-response manner 7 
Traditional methods based on population averages may mask the fact that a great 8 
variation exists in the uptake of plasmid or vector copy number for each cell within a 9 
transduced cell culture10,11. Thus, to accurately assess the dose-response effects of Lifeact 10 
expression at the cellular level, we devised an alternative approach based on pooling 11 
together single-cell data according to their measured Lifeact expression, irrespective of initial 12 
MOI or time post-transduction. Two critical aspects of our methodological approach need to 13 
be emphasised here. First, the quantification of parameters related to cytoskeleton 14 
organization and cell morphology was performed using images obtained through TRITC-15 
phalloidin staining, i.e. independently of Lifeact-GFP driven fluorescence. By doing so the 16 
cytoskeleton of cells with low Lifeact-GFP expression (displaying low GFP fluorescence 17 
intensities, Fig. 1b) could be resolved with similar accuracy to those expressing larger Life-18 
GFP levels (Fig. 1d). Second, we took advantage of the 1:1 stoichiometry between the 19 
Lifeact peptide and the GFP tag, and measured for each cell its total GFP fluorescence as a 20 
surrogate indicator of Lifeact expression12. Furthermore, we extended our previously-21 
developed image quantification pipelines13,14 to describe in a multiplex fashion the 22 
organization of the cytoskeleton and nucleus of individual cells.  23 
We constructed dose-response curves (DRC) to depict morphometric parameters as 24 
a function of intracellular GFP intensity and observed clear morphological trends linking 25 
increased Lifeact expression with altered cellular phenotypes (Fig. 2 and Supplementary 26 
Figure 4). In particular, cells displaying the highest Lifeact expression had 10-fold larger 27 
spread areas, smaller aspect ratios and a less stellate morphology (Fig. 2). Concurrently, 28 
when assessing actin organization, Lifeact expression caused a 50-fold increase in F-actin 29 
assembly (Fig. 2d), leading to stress fibres that were longer (Supplementary Fig. 4 b), 30 
thicker (Fig. 2e) and with an increasing radial orientation (Fig. 2f). To verify that the effects 31 
observed were associated with Lifeact rather than its fluorescent tag, we generated similar 32 
DRC with cells transduced with the same promoter and a GFP tag only (Supplementary Fig 33 
5). While the DRCs obtained were not so broad in terms of expression levels reached, we 34 
verified that the dose-response behaviour was lost when only GFP was transduced. In 35 
particular, multiple comparisons analysis (Supplementary Fig 5) showed that, even with the 36 
highest transduction levels reached with the pCMV-EGFP there is no significant difference 37 
5 
 
with the lowest dosage with the same treatment. Furthermore, multiple comparisions 1 
analysis also shows that, for the majority of parameters, there are significant differences 2 
between cells with the highest dose of pCMV-EGFP and cells displaying similar GFP 3 
fluorescence levels but transduced with the pCMV-Lifeact-Tag2. Additional experiments 4 
using Lifeact-GFP recombinant protein delivered into the cellular cytoplasm using a 5 
membrane fusion reagent resulted again in a dose-response behaviour that displayed 6 
marked overlap with the results obtained using adenoviral transduction of Lifeact-GFP 7 
(Supplementary Fig 5). Similar as before, for the majority of parameters, multiple 8 
comparisons analysis showed that there were significant differences between cells treated 9 
with the highest dose of pCMV-EGFP and cells treated with the highest doses of 10 
recombinant plasmid. Conversely, there were no significant differences between cells 11 
treated with the highest dosages of pCMV-Lifeact-Tag2 plasmid versus the recombinant 12 
protein. 13 
Of note, DRCs generated for all cytoskeletal parameters had at least two marked 14 
regimes (Fig. 2 and Supplementary Fig. 4), namely a dose-response behaviour for low to 15 
mid expression levels of Lifeact-GFP (white background area in panels) followed by a 16 
saturation plateau at very high expression levels (gray background area in panels). In 17 
addition, for some cytoskeletal parameters measured we could also identify a range of low 18 
Lifeact-GFP expression levels for which no dose-response effect was observed (yellow 19 
background area in panels). Similar dose-response trends were also obtained when NIH/3T3 20 
or COS-7 cells were transduced with Lifeact-GFP vector, even though overall values for 21 
parameters such as cell area or F-actin amount were different, as expected for different cell 22 
types (Supplementary Fig 6). Altogether, these data evidences that Lifeact-GFP can have a 23 
pronounced effect on cellular morphology and actin cytoskeleton organization. While at the 24 
population level these effects are largely dependent on transduction conditions (MOI and 25 
duration of expression), at the single cell level Lifeact-induced side effects display large 26 
heterogeneity, being predominantly dependent on the amount of peptide expressed by each 27 
cell.  28 
 29 
Lifeact-induced effects extend to other cytoskeletal networks and the nucleus 30 
Having confirmed the marked effects on whole cell morphology and stress fibre 31 
architecture induced by Lifeact expression, we chose to focus on Lifeact-GFP adenoviral 32 
transduction on hMSC and we next investigated cellular components with a strong link to the 33 
actin cytoskeleton, such as microtubules and intermediate filaments. We limited our protocol 34 
to MOI 1000 and 5 days post transduction -to maximise the range of Lifeact expression 35 
levels- and replaced TRITC-phalloidin staining with antibodies against tubulin and vimentin. 36 
Surprisingly, we found that increased levels of Lifeact expression were associated with a 37 
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build-up in the microtubule and intermediate filament networks (Fig. 3). Given the close 1 
interconnectedness between the three cytoskeletal networks14, we hypothesise that 2 
alterations in tubulin and vimentin assembly are a secondary result from the effects of Lifeact 3 
on cell spread area, rather than a direct interaction between Lifeact peptides and tubulin or 4 
vimentin monomers.  5 
We additionally investigated if Lifeact could also influence the nucleus, since nuclear 6 
structure is coupled to cytoskeletal organization and cellular morphology. Based on DAPI 7 
images from our previous transduction experiments, we quantified changes in three-8 
dimensional nuclear shape, mechanical attributes and chromatin condensation state14. As 9 
before, we observed that Lifeact expression altered nuclear state, giving raise to nuclei that 10 
were up to 1.5 times larger in volume and less auxetic (Fig. 4), while chromatin 11 
condensation remained unaffected (not shown). Again, we hypothesize that the effects of 12 
Lifeact on the nucleus are a secondary result of alterations in cellular morphology and 13 
cytoskeletal architecture14. Together, our results uncover for the first time that Lifeact-14 
induced artefacts on the actin cytoskeleton may have knock-on effects that extend into other 15 
critical cellular structures. 16 
 17 
Lifeact-induced effects on the cytoskeleton lead to altered cell biophysical behaviour 18 
 19 
Having established the multiple effects of Lifeact on cellular structures, we moved to 20 
examine their impact on cell biophysical behaviour. First, we used atomic force microscopy 21 
to probe the nanomechanical properties of Lifeact-transduced cells. Our results showed a 22 
mild decrease in cellular stiffness at very large peptide concentrations together with a steady 23 
dose-response increase in cellular viscosity (Fig. 5). These results were initially surprising, 24 
as we have previously shown a strong correlation between F-actin assembly and cellular 25 
stiffness13. Nevertheless, it’s worth stressing that cells with very large levels of Lifeact 26 
expression displayed thick fibres disjointed from each other (cell #2 in suppl. Fig 7), 27 
sometimes leaving between them large cell areas devoid of any actin-rich structure. This 28 
scenario is thus very different from the previously described nematic phase of actin 29 
organization15 (cell #1 in suppl Fig 7) and may rather resemble the liquid-like behaviour of 30 
actin structures recently observed in vitro after coalescence and shortening of actin 31 
bundles16.  32 
Increasing evidence points towards the YAP/TAZ pathway as a crucial regulator of 33 
cellular mechanosensing in stem cells17. In particular, the translocation of YAP into the cell 34 
nucleus constitutes a hallmark of increased intra or extracellular forces that are transmitted 35 
through the cytoskeleton and to the nucleus18. Accordingly, we set to quantify whether YAP 36 
intracellular localization would be affected by Lifeact transduction, as a second evidence of 37 
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altered cell biophysical properties. To this end, we quantified the ratio of nuclear to cytosolic 1 
YAP and observed that cells with higher Lifeact-GFP expression had lower amount of YAP 2 
in the nucleus when compared to weakly-transduced cells (Figure 6a). Furthermore, we 3 
explored whether the ratio of nuclear to cytosolic YAP correlated with cell spread area, as 4 
found by others19. In control cells (not transduced) we found a constant value of nuclear to 5 
cytosolic YAP ratio that was not modulated by cell area (Figure 6b). Conversely, for cells 6 
transduced with Lifeact, nuclear to cytosolic YAP ratios were overall larger, and they tended 7 
to decrease with increasing cell area (Figure 6b). This behaviour is reminiscent of that 8 
observed in Figure 5a for cellular stiffness, and may reflect a mild decrease is intracellular 9 
tension with increasing Lifeact expression that then results in decreased nuclear 10 
translocation of YAP. Of note, immunostaining images of YAP used for this analysis showed 11 
a striking unexpected feature, that is, Lifeact-dense stress fibres appeared to be decorated 12 
with YAP, a feature that was not observed in control cells (Figure 6c). In both cases, the 13 
preferred nuclear localization of YAP was preserved. Furthermore, we verified that this 14 
observation was not due to bleed-through between the GFP and TRITC fluorescence 15 
signals, or unspecificity of the TRITC-tagged secondary antibody used throughout this study 16 
(supplementary Figure 8). Conversely, our analysis shows that YAP colocalization with F-17 
actin fibres increases with increasing Lifeact expression levels (Figure 6d). 18 
 19 
As a third biophysical behaviour, we evaluated whether Lifeact expression would 20 
affect cell motility by performing long-term live cell imaging 5 days post-transduction. 21 
Individual cells were tracked by acquiring fluorescence images of the GFP channel every 10 22 
minutes over a period of 18 hours and the resulting videos were later analysed using the 23 
same image analysis pipeline as before. In addition to the parameters describing 24 
cytoskeletal organization presented above, we also computed the total distance migrated by 25 
each cell along with the directionality of migration (Fig. 7). We found that cells displaying low 26 
Lifeact expression migrated for longer distances in a less directed fashion. Conversely, cells 27 
with intermediate Lifeact expression tended to exhibit shorter but directionally-persistent 28 
trails, consistent with our previous finding that these cells tend to display more aligned stress 29 
fibers (Supplementary Fig. 4 d, Supplementary videos). Finally, cells with very high levels 30 
of Lifeact expression exhibited severely impaired migration, remaining quasi-static and 31 
erratic in their displacements. Of note, cells that had lower Lifeact expression did reorganize 32 
their cytoskeleton to a larger extend in the timeframe of minutes, as shown by the frame-to-33 
frame changes in F-actin assembly (Fig. 7 c). Accordingly, we hypothesize that the impaired 34 
migration displayed by cells expressing high levels of Lifeact expression is due to reduced F-35 
actin dynamics when reorganizing their cytoskeleton. 36 
 37 
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Impaired cofilin binding to F-actin as an underlying mechanism for the Lifeact-1 
induced aberrations in actin organization and dynamics 2 
 3 
Finally, we set out to pinpoint the potential mechanism by which Lifeact alters F-actin 4 
organization and dynamics. Cofilin was identified as a plausible key player, since Lifeact has 5 
been suggested by others to impair actin filament severing by cofilin both in vitro and in 6 
yeast cells6. We thus carried out several experiments to assess if and how Lifeact 7 
expression led to reduced cofilin activity. On the one hand, we followed the procedure 8 
devised by Hotulainen et al., which elegantly show that the G-actin sequestering drug 9 
Latrunculin A (LatA) fails to depolymerize the actin cytoskeleton when cofilin activity is 10 
impaired20. We incubated Lifeact-transduced cells with LatA and simultaneously conducted 11 
live-cell fluorescence imaging for 30 minutes at 2-minute intervals. By measuring the relative 12 
drop in F-actin amount during treatment, we verified that Lifeact reduced LatA-induced 13 
cytoskeletal depolymerisation in an expression-dependent manner (Fig. 8 a). While this 14 
experiment suggested that Lifeact inhibits cofilin activity, it did not identify whether the 15 
underlying mechanism is associated with chemical inactivation of cofilin (via phosphorylation 16 
at serine residue 321) or conformational changes of the f-actin filament upon Lifeact binding 17 
that prevent cofilin binding2,6. Accordingly, we performed western blot measurements of 18 
cofilin and p-cofilin expression levels for cell populations transduced with Lifeact or controls 19 
(Fig. 8 b, Supplementary Fig. 9). Cells transduced with Lifeact displayed 81% increase in 20 
overall cofilin expression, while the expression levels of p-cofilin increased only by 51%. 21 
Together, these results suggest that Lifeact-transduced cells have higher total amounts of 22 
cofilin, and that a lower percentage of said cofilin is in the inactive phosphorylated state. 23 
Finally, we performed immunostaining against cofilin to assess whether the drop in cofilin 24 
activity was associated with changes in cofilin binding to F-actin. Following the approach 25 
devised by Hayakawa et al22 using fluorescence image quantification, we measured 26 
fluorescence intensity levels of cofilin in pixels previously identified as corresponding to an F-27 
actin fibre, thus obtaining a measure of cofilin colocalization to F-actin. When we produced 28 
dose-response curves, we found that cells with higher expression of Lifeact had lower 29 
amount of cofilin colocalization (Fig. 8 c). Collectively, our results reinforce the hypothesis 30 
proposed by Courtemanche et, where Lifeact binding to F-actin induces a conformational 31 
change in actin filament structure which is then incompatible with subsequent cofilin 32 
binding6. This hypothesis should be contextualized with recent findings on the dual activity of 33 
cofilin, involving both severing and depolymerisation of actin filaments23. Of note, saturation 34 
of actin filaments with cofilin dramatically changes their dynamics towards a 35 
depolymerisation-prone state from both barbed and pointed ends23. Our findings, together 36 
with those of others6,23, support the hypothesis that prior binding of Lifeact to actin filaments 37 
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would prevent cofilin saturation of said filaments, thus inhibiting cofilin-induced actin 1 
depolymerisation and reducing overall actin filament dynamics.   2 
 3 
Discussion 4 
 5 
In summary, our results suggest that Lifeact-GFP induces dose-response alterations 6 
in the actin cytoskeleton, likely stemming from altered cofilin activity and reduced filament 7 
dynamics. The effects extend beyond the actin cytoskeleton, also affecting other cytoskeletal 8 
structures and impairing the overall biophysical behaviour of cells.  9 
 10 
Our findings are more strongly marked in undifferentiated human stem cells, which 11 
may be due to a higher capacity to uptake the adenovirally-delivered Lifeact plasmid. 12 
Nevertheless, we obtain similar dose-response trends in immortalized cell lines (NIH/3T3 13 
and COS-7), thus expanding the range of cells types were Lifeact has been shown to induce 14 
aberrant morphologies8,9,24. It is worth stressing that, in our hands, Lifeact affects different 15 
cells types to a different degree, and some cytoskeletal features more strongly than others.  16 
An illustrative example of a trend being missing is the parameter stellate factor for COS-7 17 
cells (supplementary figure 6b, blue symbols). Stellate factor measures the tendency of a 18 
cell to display filopodia projections or protuberances (high value of stellate factor). Indeed, 19 
COS-7 cells are rather smooth in their perimetral appearance, and don’t typically extend 20 
protrusions. Being that the case, it is difficult to see a trend towards decreasing this value, 21 
because even in control conditions this value is low to begin with. Nevertheless, we note that 22 
the dose-response trends are typically preserved between cell types, thus suggesting a 23 
common origin of the observed changes. The Lifeact plasmid we used included a CMV 24 
promoter, which has been shown by others to induce milder aberrations than pBABE and 25 
CAG8. Of note, our results using a recombinant Lifeact-GFP protein show that the effect of 26 
Lifeact is similar regardless of the way in which the DNA (or protein) is delivered and 27 
expressed into the cell. Similarly, the GFP tag used (TagGFP2) is a next-generation 28 
monomeric fluorescent protein, again being linked to milder aberrations than other 29 
dimerization-prone GFP tags8. Our results are thus obtained in conditions identified by 30 
others as conductive to fewest aberrant morphologies in terms of choice of promoter and 31 
fluorescence protein tag used. In spite of that, we find a dose-response effect at all MOI and 32 
conditions used, thus raising concerns on the use of Lifeact as a cytoskeletal marker.   33 
 34 
Given that the effects of Lifeact in cytoskeletal organization exhibit a dose-response 35 
behaviour with a saturation plateau, our results bring new light to the difficult compromise 36 
during transduction optimization, that is, maximising the number of transduced cells while 37 
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reducing the number of cells which are either dead or with aberrant morphologies. Contrary 1 
to expected, for all transduction protocols that we tested, the number of cells that are 2 
transduced but not aberrant is constant and much lower than anticipated (<20%) 3 
(Supplementary Fig. 10). Lifeact transduction protocols found in published literature vary to 4 
a certain degree between laboratories and also according to cell lines used. It may then be 5 
difficult to judge, when optimizing a transduction protocol, whether experiments are being 6 
carried out in non-artifactual conditions based only on MOI estimates. We propose an 7 
alternative approach, that is, that the presence of few clearly obvious aberrant cells (gray 8 
bars in Supplementary Fig. 10) should be used as a tell-tale sign that a large percentage of 9 
cells are within the dose-response regime (white bars in Supplementary Fig. 10) and that 10 
few cells will be truly non-artifactual. We note here that transduced cells that display minor 11 
aberrations are likely to go unnoticed to the naked eye during the course of an experiment. 12 
Selection of these cells in a study will lead to experimental bias or lack of reproducibility with 13 
results obtained using other live cell actin probes. Prior to performing experiments, it is 14 
important researchers establish a reliable protocol to identify and select only suitable cells 15 
within the whole population of heterogeneously transduced cells. Similarly, it would be 16 
advisable to report the percentages of not-affected, aberrant and grossly-aberrant cells 17 
within the cell population for any given transduction protocol used in a study. Preliminary 18 
tests based on co-staining with an actin marker such as phalloidin and image quantification 19 
at the single cell level can provide this type of information in a swift manner. With this study, 20 
we hope to start an active discussion on what are the limits of suitability of our current live-21 
cell cytoskeletal reporters. This is a timely and much-needed debate, especially with the 22 
advent of other actin reporters, such as SiR-actin, Utrophin or F-tractin, which may display 23 
similar associated issues. 24 
 25 
 26 
Methods 27 
Cell culture, Lifeact-GFP transduction and immunostaining. Unless stated otherwise, all 28 
chemicals and reagents were obtained from Sigma. The majority of measurements were 29 
performed in human bone marrow derived mesenchymal stem cells (Promocell), while 30 
additional measurements were performed in NIH/3T3 and COS-7 cells. Cells were 31 
maintained in culture medium consisting of low glucose Dulbecco’s Modified Eagle Media 32 
(Gibco) supplemented with 10% foetal bovine serum, and 100U/ml Penicillin- 100µg/ml 33 
Streptomycin. hMSCS were additionally supplemented with 10 ng/ml fibroblast growth factor 34 
(Peprotech). Cells were kept in tissue culture flasks and cultured at 37°C and 5% CO2. 35 
Mesenchymal stem cells were used between passages 5 and 9. Lifeact-GFP transductions 36 
11 
 
were performed using commercial rAV-CMV-LifeAct-TagGFP2 Adenoviral Vectors (Ibidi) 1 
according to supplier’s instructions, by addition of viral transduction reagent volumes 2 
required to achieve the desired MOI (i.e. 100, 300, 600 or 1000) on each sample. After the 3 
initial 18 hours of incubation for vector uptake, media containing viral particles was 4 
exchanged. Cell samples were allowed to express Lifeact-GFP for a total of 1, 3, 5 or 7 days 5 
prior to fixation.  The pCMV-EGFP plasmid was a kind gift from Dr Julien Gautrot. For 6 
experiments using recombinant Lifeact-GFP protein, Lifeact-TagGFP2 peptides and 7 
proprietary Fuse-it-P intracellular protein delivery kits were acquired from Ibidi and prepared 8 
according to instructions. Briefly, hMSCs were seeded into coverslips inside 6-well TCP 9 
vessels, three days before experiments. Lyophilised peptides were reconstituted in sterile 10 
water, and further diluted in 20mM HEPES buffer to a concentration of 0.1 mg/ml. Fuse-it-P 11 
was loaded with peptides by following supplier's instructions. Cells were washed in PBS, and 12 
1ml of 1:50 fusogenic mixture was dispensed to each well. After incubation for 5 minutes at 13 
37ºC, fusogenic mixture was replaced with cell culture medium and returned to an incubator. 14 
Cell samples were fixed after 6 hours, to mitigate toxicity effects, stained and imaged as 15 
before. All live cell experiments (migration, AFM and Latrunculin-A treatment) were 16 
conducted on cells transduced at MOI 1000, at 5 days post transduction. The same 17 
conditions were used for NIH3/3 and COS-7 cells. At least 3 independent transductions were 18 
performed for each set of experiments. 19 
For live cell imaging experiments, cells were directly plated onto 6-well plates and 20 
cultured in FBS and antibiotic supplemented Flurobrite-DMEM imaging specific media 21 
(Thermofisher). For AFM measurements, cells were plated in petri dishes and imaging 22 
media were supplemented with 50 mM HEPES. For immunostaining experiments, cells were 23 
sparsely seeded onto serum coated coverslips inside sterile petri dishes at least 1 day prior 24 
to transductions. In brief, cells were fixed by treatment with 3.7% paraformaldehyde in PBS 25 
for 15 min and permeabilised for 5 min in 0.25% Triton X-100. To visualize simultaneously F-26 
actin via Lifeact and Phalloidin, cells were stained with phalloidin-TRITC at 2 μg/ml in PBS 27 
for 2 hours. For additional immunostaining experiments to visualize other cytoskeletons and 28 
proteins, permeabilized cells were treated overnight with primary antibodies against vimentin 29 
(1:400 dilution; RV202), α-tubulin (1:50 dilution; TU-02), YAP (1:200, 63.7) and cofilin (1:200; 30 
E-8) diluted in goat serum blocking buffer at 4 °C (all antibodies mouse monoclonal from 31 
Santa Cruz Biotechnologies). The next morning, the samples were washed with PBS and 32 
treated with a TRITC-tagged secondary antibody (1:400 dilution, goat anti-mouse IgG-33 
TRITC, sc-3796) for 1 hour at room temperature. All coverslips were mounted onto glass 34 
slides using ProLong® Gold Antifade Mountant containing DAPI (Thermo Fisher). Control 35 
samples were cultured and stained in parallel to transduced cell cultures, but without having 36 
been subjected to the transduction protocol.    37 
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 1 
Quantification of cell morphology, cytoskeletal structures and nuclear state from 2 
fluorescence images. All fixed samples were imaged using an inverted epifluorescence 3 
microscope (Leica DMI4000B) with a x20/0.50 NA objective lens and a CCD camera (Leica 4 
DFC300FX). Cells were sequentially imaged on the DAPI (nuclei), TRITC 5 
(phalloidin/antibody staining), and FITC (Lifeact-GFP) channels. The algorithm for single-cell 6 
quantification of cytoskeleton structures has been described in previous publications13,14. 7 
The coded algorithm (CSKMorphometrics) has been implemented in MATLAB (Mathworks) 8 
and can be found at the File Exchange repository at MATLAB central site. In brief, the 9 
quantification of cell morphology and cytoskeleton configuration is based on three steps: (1) 10 
initial fibre segmentation, (2) fibre refinement, and (3) determination and subtraction of 11 
background. These steps output a variety of maps representing either the brightness of 12 
segmented fibres or local fibre orientation, that allow subsequent estimation of morphometric 13 
parameters for individual cells. This information is assembled into 14 descriptors 14 
(Supplementary Information), e.g. cell spread area, total fibre amount. For the present study, 15 
we use the term ‘fibre amount’ to signify the amount of protein organized in fibres, that is, 16 
identified by the pipeline as part of the segmented cytoskeleton in the raw image. 17 
Quantification of nuclear features to estimate relative nuclear mechanical parameters 18 
is described elsewhere14. With this method we process DAPI-stained nuclei images to 19 
quantify nuclear volume, Poisson ratio and chromatin state in individual cells.  20 
Finally, the total intensity from GFP images belonging to individual cells was used as 21 
a metric for intracellular Lifeact amount to produce graphs correlating cellular morphometrics 22 
with peptide expression. Total GFP intensity was measured by adding up the fluorescence 23 
intensity measured for all pixels within the outline of a cell, once background intensity was 24 
subtracted. To statistically identify the three regimes in the dose-response curves, namely a 25 
no effect regime, a dose-response regime, and a saturation plateau, threshold points were 26 
calculated across all parameters by adapting a method previously developed by us and 27 
based on the ratio of variances (RoV)25 around each point of a DRC (Fig. 2-8 and 28 
Supplementary Fig. 4). Briefly, a test parameter RoV is defined as 𝑅𝑜𝑉i =
𝑣𝑎𝑟(𝑑𝑖+1:d𝑖+𝑁)
𝑣𝑎𝑟(𝑑i−𝑁:𝑑i−1)
, i.e. 29 
the ratio of the variances computed in two N-sized small windows to each side of every point 30 
i in each DRC. Peaks in RoV displaying regions of high variability in the data, signifying a 31 
transition between regimes, were identified in each DRC curve. Two global GFP intensity 32 
values corresponding to the transitions point to dose-response and saturation regimes were 33 
obtained by averaging out all threshold GFP intensities obtained in figures 2-8 and 34 
supplementary figure 4. The values for the two global GFP intensity thresholds are 35 
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included in supplementary fig 2 and were used to sort individual cells into the 3 regimes 1 
depicted in supplementary figure 10. 2 
 3 
Quantification of Nuclear/Cytosolic ratio of YAP . Nuclear/Cytosolic ratio of YAP was 4 
assessed as previously described by others18. Briefly, we measured the average 5 
fluorescence intensities of YAP staining in the nucleus and in an annular region with equal 6 
size in the cytosol immediately adjacent to the nuclear region, and computed their ratio. 7 
 8 
Western Blotting. Cells were washed with chilled PBS and lysed in RIPA buffer for 15 min 9 
on ice. The total protein concentration was determined by the BCA assay. Cell lysates were 10 
mixed with Laemmeli buffer and denatured by heating at 100°C for 5 min. Proteins were 11 
separated by SDS–PAGE and transferred onto a nitrocellulose membrane. Membranes were 12 
blocked in 5% dry milk for 1 h, followed by incubation with primary antibodies for cofilin 13 
(1:125, E-8, Santa Cruz), p-cofilin (1:250, E-5 Santa Cruz) and control glyceraldehyde 3-14 
phosphate dehydrogenase (GAPDH) (1:500, 0411, Santa Cruz) over night at 4 ℃. Excess of 15 
antibody was removed by washing with PBST three times and the secondary antibody 16 
donkey anti-mouse (IRDye® 680RD Donkey anti-Mouse IgG (H + L), [P/N 926-68072]; 17 
1:10000) was added for 1h at room temperature in dark. The proteins recognized by the 18 
antibody were visualized by chemiluminescence. ImageJ was used to quantify the intensity 19 
of cofilin, p-cofilin and GAPDH protein bands from each blot. 20 
 21 
Migration and cytoskeleton disassembly experiments. For migration and Latrunculin-A 22 
treatment experiments, live-cell imaging was performed under temperature and CO2 23 
controlled environment, using an incubator-encased epifluorescence imaging system 24 
(Lumascope 720, Etaluma) at x20 magnification. Transduced cells were cultured inside 6-25 
well plates until the time of imaging. Individual cells were continuously tracked for 18 hours 26 
at 10-minute intervals, and imaged in the FITC channel. To produce Supplementary videos 27 
of long term behaviour in Lifeact-GFP expressing cells, imaging was conducted under similar 28 
conditions using 10x magnification for a period of 4 days, sampled at 1-hour intervals. 29 
Control cells remained untransduced for the duration of the experiment. Other conditions 30 
consisted of cells transduced at MOIs of 250 or 500. 31 
To characterize migration patterns, every frame on the 18 hours time-lapse video 32 
pertaining to the Lifeact-GFP channel was analysed using the formerly described image 33 
processing algorithms. The positions of cell centroids were tracked from masks of 34 
instantaneous cell shape and used to quantify total distance migrated. Migration 35 
14 
 
directionality was defined as the ratio between net cell displacement (the euclidian distance 1 
between starting and ending centroid positions) and the overall distance travelled by the cell, 2 
as 𝑀𝐷 =
𝑑(𝑃𝑡=0,𝑃𝑡=𝑇)
∑ 𝑑(𝑃𝑡=𝑖,𝑃𝑡=𝑖+1)
𝑇
𝑖=0
. F-actin interframe change was calculated comparing values of F-3 
actin (FA) between successive frames, as 𝐼𝐹𝐶𝑖 = 100 ∙
𝐹𝐴𝑖+1−𝐹𝐴𝑖
𝐹𝐴𝑖
. For cytoskeleton 4 
disassembly studies, cells were imaged for 30 minutes at 2-minute intervals immediately 5 
upon addition of Latrunculin A (0.075µg/ml) to the culture medium. F-actin disassembly was 6 
quantified as 100 ∙
𝐹𝐴𝑡=0𝑚𝑖𝑛−𝐹𝐴𝑡=30𝑚𝑖𝑛
𝐹𝐴𝑡=0𝑚𝑖𝑛
 7 
 8 
 9 
Determination of cellular stiffness and viscosity with atomic force microscopy. All 10 
measurements of cell mechanics were performed on a Nanowizard 4 (JPK), integrated with 11 
an Axio Observer Z.1 epifluorescence microscope with Plan-Apochromat lenses (20x) 12 
equipped with a cooled CMOS camera (Orca Flash 4). Cells were probed using gold-coated 13 
rectangular cantilevers (0.03 N/m nominal spring constant) with pyramidal tips (12 µm high 14 
with 35° half cone angle, supplied by BudgetSensors). Experiments were conducted on petri 15 
dishes mounted on a heating accessory to maintain cells at 37º C. AFM experiments were 16 
conducted for a maximum of 1hr per petri dish. Prior to measurement, the cantilevers were 17 
allowed to thermally equilibrate fully submerged in cell media. The cantilever sensitivity was 18 
calibrated in contact mode on a bare region of the container, following which the cantilever 19 
was moved a minimum of 500 µm from the surface to calibrate the force constant using 20 
thermal fluctuations. We identified individual adherent cells exhibiting varied levels of GFP 21 
expression and recorded a fluorescence image of the GFP channel at 20× magnification 22 
before measuring cell mechanics. Imaging parameters (exposure time and gain) were kept 23 
constant for all experiments. AFM measurements were performed using JPK’s QI mode, 24 
which rapidly acquires force-curves generating a detailed image of the topography and 25 
mechanical properties of the sample. For each measurement we selected a region of 100 by 26 
100 µm (32x32 force curves) ranging from lamellar and cytosolic to nuclear regions of the 27 
cell. Force curves had a z-length of ~10 µm, extension speed of 125 µm/s and a setpoint of 28 
3-5 nN.  29 
Data analysis of the force-displacement curves was carried out using the BECC 30 
model for thin adherent cells on a stiff substrate25 using a pipeline written in MATLAB as 31 
previously described25. Cellular viscosity was computed using the same force-displacement 32 
curves following the method outlined by Rebelo et al 27. 33 
 34 
15 
 
Statistical Analysis. Statistical tests were produced with the OriginLab analysis software. 1 
Population results were plotted as box charts presenting median values and first and third 2 
quartiles, with error bars indicating the 1st and 99th quartiles. Single cell results were 3 
expressed either as means or geometric means with error bars representing interquartile 4 
range. Two-way ANOVA tests were used to establish the significance of concentration and 5 
time effects on the levels of Lifeact expression and of morphological alterations of cell 6 
populations. Dunnett’s post-hoc tests where used to determine significant differences 7 
between the control group (no transduction) and groups treated with increasing MOIs for 8 
each day measured. 9 
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Figure captions 1 
Figure 1 | Characteristic phenotypes of cells expressing increasing amounts of Lifeact-GFP 2 
and co-stained with phalloidin-TRITC and DAPI. (a) Cell cultured on a coverslip dish that 3 
was not transduced, (b) cell sorted as ‘no-effect regime’, (c) cell sorted as ‘dose-response-4 
regime’, (d) cell sorted as ‘saturation plateau’. Scale bar corresponds to 15 µm and is the 5 
same for all cells pictured. 6 
 7 
Figure 2 | Dose-response curves quantifying the effect of Lifeact expression in cell spread 8 
area (a), cell perimeter stellate factor (b), aspect ratio (c), f-actin amount (d), fibre thickness 9 
(d) and chirality of fibres (f).  Values for >100 cells were pooled together to compute each 10 
individual data point. Data is presented as geometric mean (a and d), mean (b and e) or 11 
median (c and f) error bars indicate geometric standard deviation, standard deviation or Q1-12 
Q3, accordingly. Background colours indicate the regimes where cells display no Lifeact-13 
induced effect (yellow background), a dose-response trend (white background) and a 14 
saturation plateau (gray background), as identified from analyses of peak changes in 15 
variability in the neighbourhood of each point for each parameter plotted.   16 
 17 
Figure 3 | Lifeact-driven effects extend to non-actin-based cytoskeletal networks. 18 
Quantification of Lifeact effects on intermediate filaments assembly (a) and microtubule 19 
assembly (b). Values for >40 cells were pooled together to compute each individual data 20 
point. Data is presented as geometric mean, error bars indicate geometric standard 21 
deviation. Background colours indicate the regimes where cells display no Lifeact-induced 22 
effect (yellow background), a dose-response trend (white background) and a saturation 23 
plateau (gray background), as identified from analyses of peak changes in variability in the 24 
neighbourhood of each point for each parameter plotted.   25 
 26 
Figure 4 | Lifeact-driven effects modulate nuclear state. Quantification of Lifeact effects on 27 
nuclear volume (a) nuclear Poisson’s Ratio (b). Values for >40 cells were pooled together to 28 
compute each individual data point. Data is presented as mean, error bars indicate standard 29 
deviation. Background colours indicate the regimes where cells display no Lifeact-induced 30 
effect (yellow background), a dose-response trend (white background) and a saturation 31 
plateau (gray background), as identified from analyses of peak changes in variability in the 32 
neighbourhood of each point for each parameter plotted.   33 
20 
 
Figure 5 | Lifeact expression alters cellular mechanical properties. Lifeact dose dependent 1 
effects on cell stiffness (a), and viscosity (b) Values for >10 cells were pooled to compute 2 
each individual data point. Data is presented as geometric mean, error bars indicate 3 
geometric standard deviation. Background colours indicate the regimes where cells display 4 
no Lifeact-induced effect (yellow background), a dose-response trend (white background) 5 
and a saturation plateau (gray background), as identified from analyses of peak changes in 6 
variability in the neighbourhood of each point for each parameter plotted.   7 
 8 
Figure 6 | Lifeact expression alters intracellular localization of YAP. Ratio of nuclear to 9 
cytoplasmic YAP localization according to Lifeact-GFP cellular fluorescence (a) and cell area 10 
(b). In (b), black symbols correspond to cells not transduced (control) and red symbols 11 
correspond to cells transduced with Lifeact-GFP.  (c) Example cells displaying localization of 12 
YAP staining to Lifeact-containing stress fibres. The cell on the left was transduced with 13 
Lifeact and the cell on the right was not transduced. After fixation, cells were stained with 14 
DAPI (middle panels) and against YAP (bottom panels). Scale bar is 50 µm. (d) Average 15 
pixel intentisty of YAP fluorescence colocalized to Lifeact-containing stress fibres is 16 
dependant on the total amount of Lifeact expressed in the cell. Data is presented as mean, 17 
error bars indicate standard deviation. For (a) and (d), background colours indicate the 18 
regimes where cells display no Lifeact-induced effect (yellow background), a dose-response 19 
trend (white background) and a saturation plateau (gray background), as identified from 20 
analyses of peak changes in variability in the neighbourhood of each point for each 21 
parameter plotted.  Values for >12 cells were pooled to compute each individual data point. 22 
 23 
Figure 7 | Lifeact expression alters cell migration and F-actin dynamics. Lifeact dose 24 
dependent effects on distance migrated (a), directionality of migration (b) and F-actin inter-25 
frame changes (c). Values for >5 cells were pooled to compute each individual data point. 26 
Data is presented as geometric mean, error bars indicate geometric standard deviation. 27 
Background colours indicate the regimes where cells display no Lifeact-induced effect 28 
(yellow background), a dose-response trend (white background) and a saturation plateau 29 
(gray background), as identified from analyses of peak changes in variability in the 30 
neighbourhood of each point for each parameter plotted.   31 
 32 
Figure 8 | Lifeact expression alters cofilin activity. (a) Lifeact dose dependent effects on F-33 
actin disassembly after 30 min of Latrunculin A (0.075µg/ml) treatment. (b) Western blot 34 
21 
 
results for cofilin and p-cofilin expression levels relative to GADPH. (c) Lifeact dose 1 
dependent effects on fluorescence intensities of cofilin colocalized to F-actin fibres. For (a) 2 
and (c), data is presented as median, error bars indicate Q1-Q3, N>100 cells; for (b) data is 3 
presented as mean, error bars indicate standard deviation, N=3 repeats. 4 
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